Navigation Links
Sex Hormone Protein May Predict Type 2 Diabetes
Date:8/5/2009

Whether it causes the disease or is simply a marker for obesity is unclear ,,

WEDNESDAY, Aug. 5 (HealthDay News) -- A protein that carries and activates sex hormones throughout the body may also predict those at high risk of developing type 2 diabetes, a new study finds.

The protein, called sex hormone-binding globulin (SHBG), regulates the levels of testosterone and estrogen in the blood. Researchers suspect it also plays a role in the development of type 2 diabetes.

"Basically, we have identified plasma SHBG as a strong and significant marker for type 2 diabetes development in initially healthy men and women," said lead researcher Dr. Simin Liu, professor and director of the Center for Metabolic Disease Prevention in the School of Public Health at the University of California Los Angeles, David Geffen School of Medicine.

Low levels of SHBG were a significant predictor for the risk of development of type 2 diabetes, the researchers found.

"To our knowledge, there are few biomarkers for type 2 diabetes prediction that have presented both genetic and plasma phenotypic evidence like ours," Liu said.

The report was published in the Aug. 5 online edition of the New England Journal of Medicine.

For the study, Liu's group looked at SHBG levels in 718 postmenopausal women -- 359 with type 2 diabetes and 359 without -- who participated in the Women's Health Study, a large-scale cardiovascular trial begun in 1993. In a separate investigation, they confirmed their findings in a group of 340 men who participated in the Physicians' Health Study II, a similarly large study.

Besides the inverse relationship between levels of SHBG and type 2 diabetes, they identified two genetic variants in the gene coding for SHBG -- one increases type 2 diabetes risk while the other decrease diabetes risk.

"Plasma SHBG appeared to predict type 2 diabetes risk beyond traditional risk factors," Liu said. "In direct comparison, it significantly outperformed some newer risk predictors such as HbA1c (glycated hemoglobin) and C-reactive protein."

The researchers also used genetic data to confirm that SHBG may play a causal role in the development of type 2 diabetes.

"Our findings provide further support of the importance of the sex-hormone biology, an area of diabetic pathogenesis which has been relatively less well-studied," Liu said.

While the exact causal mechanism involved in SHBG levels and type 2 diabetes are unclear, it appears that SHBG is involved in complex chemical interactions that can increase or decrease the risk for the disease, the researchers say.

Until now, classical thinking and teaching in medicine have never focused on the potential causal role of SHBG in the development of disease, Liu noted. "By directly linking SHBG with diabetes risk at both genetic and plasma levels, our data suggest that SHBG may have important biological effects that go beyond simply regulating sex-hormones in the blood," he said.

These findings provide new insights into the mechanisms underlying the relationship between sex-steroid hormone metabolism and type 2 diabetes, Liu said.

About 24 million Americans have diabetes, mostly type 2, and another 57 million have pre-diabetes, according to the U.S. Centers for Disease Control and Prevention.

"If our initial findings are confirmed, it is our hope that someday SHBG would serve as a critical screening tool for diabetes as well as a target for developing treatment and preventive measures," he said.

Dr. Robert Rapaport, chief of the division of pediatric endocrinology and diabetes at Mount Sinai School of Medicine in New York City, said much is still unknown about the precise association between SHBG and type 2 diabetes.

"SHBG is emerging from a role as just a carrier protein to being a player on its own," Rapaport said.

Rapaport noted that SHBG has been linked to obesity. "So you don't know which came first. Are these genes expressed more in the framework of obesity or not? Clearly, obesity is the main risk factor for type 2 diabetes. Whether or not this is an additional risk factor will be interesting to know," he said.

More information

For more information on type 2 diabetes, visit the National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: Simin Liu, M.D., Sc.D., professor and director, Center for Metabolic Disease Prevention, School of Public Health, University of California Los Angeles, David Geffen School of Medicine; Robert Rapaport, M.D., director, Hall Family Center for Pediatric Endocrinology and Diabetes, Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes, Mount Sinai School of Medicine, New York City; Aug. 5, 2009, New England Journal of Medicine, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Drop in breast cancer incidence linked to hormone use, not mammograms
2. Researchers develop long-lasting growth hormone
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
5. Most Women Unaware of Hormone Replacement Study
6. Survival data presented from phase II study of hormone-resistant prostate cancer patients
7. Hormone May Play Key Part in Creating Memories
8. Hormone Therapy for Prostate Cancer Linked to Heart Risks
9. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
10. New data on hormone therapy must lead to re-evaluation of official guidelines
11. From Hot Flashes to Breast Cancer: ZRT Labs Hormone Testing Catches On As Women Consider Safer, More Natural Options.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sex Hormone Protein May Predict Type 2 Diabetes 
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: